Isotechnika raises C$25.1 million

Isotechnika (TSE:ISA), which is in Phase II testing of its ISATX247 immunosuppressant, raised C$25.1 million (US$16.5 million) through the sale of 5.7 million special warrants at C$4.40. The deal has ...